Alnylam Promotes Greene to President, Zubarev Joins Sage-N-Research's SAB, Cellzome Appoints SAB Members | GenomeWeb
NEW YORK (GenomeWeb News) - Alnylam Pharmaceuticals has promoted Barry Greene from COO to president and COO, the firm announced today. He will continue to report to CEO John Maraganore. Prior to Alnylam, Greene was general manager of oncology at Millennium Pharmaceuticals.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.